Indrayani Biotech reports unaudited Q2 and H1 FY2025 results; board approves, a director resigns, and committees are reconstituted. BSE compliance issue resolved with a fine payment; results published on company and BSE sites.
AI Assistant
Indrayani Biotech Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.